{'52WeekChange': -0.0009009242,
 'SandP52WeekChange': 0.0644362,
 'address1': '131 Oyster Point Boulevard',
 'address2': 'Suite 600',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 22.79,
 'askSize': 3100,
 'averageDailyVolume10Day': 620625,
 'averageVolume': 582293,
 'averageVolume10days': 620625,
 'beta': None,
 'beta3Year': None,
 'bid': 21.4,
 'bidSize': 3200,
 'bookValue': 4.958,
 'category': None,
 'circulatingSupply': None,
 'city': 'South San Francisco',
 'companyOfficers': [],
 'country': 'United States',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 22.66,
 'dayLow': 21.6,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': -9.656,
 'enterpriseToRevenue': 54.941,
 'enterpriseValue': 1251829504,
 'exDividendDate': None,
 'exchange': 'NMS',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fiftyDayAverage': 26.259142,
 'fiftyTwoWeekHigh': 35.93,
 'fiftyTwoWeekLow': 13.64,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 51947735,
 'forwardEps': -1.87,
 'forwardPE': -11.860963,
 'fromCurrency': None,
 'fullTimeEmployees': 126,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'heldPercentInsiders': 0.17399,
 'heldPercentInstitutions': 0.62319,
 'industry': 'Biotechnology',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1577750400,
 'lastMarket': None,
 'lastSplitDate': None,
 'lastSplitFactor': None,
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/alector.com',
 'longBusinessSummary': 'Alector, Inc., a clinical stage biopharmaceutical '
                        'company, develops therapies for the treatment of '
                        'neurodegeneration diseases. Its products include '
                        'AL001, a humanized recombinant monoclonal antibody, '
                        'which is in phase II clinical trial for the treatment '
                        'of frontotemporal dementia disease; and AL101 that is '
                        'in Phase I clinical trial for the treatment of '
                        "neurodegenerative diseases, including Alzheimer's and "
                        "Parkinson's diseases. The company also offers AL002 "
                        'and AL003, which are in phase 1b clinical trial for '
                        "the treatment of Alzheimer's disease. In addition, it "
                        'has 10 programs under research and development stage. '
                        'The company has a collaboration agreement with '
                        'Adimab, LLC for the research and development of '
                        'antibodies. Alector, Inc. was founded in 2013 and is '
                        'headquartered in South San Francisco, California.',
 'longName': 'Alector, Inc.',
 'market': 'us_market',
 'marketCap': 1752956416,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_249249899',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': -126844000,
 'nextFiscalYearEnd': 1640908800,
 'open': 22.66,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': 0.89,
 'phone': '415 231 5660',
 'previousClose': 22.29,
 'priceHint': 2,
 'priceToBook': 4.473578,
 'priceToSalesTrailing12Months': 76.93467,
 'profitMargins': 0,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 22.66,
 'regularMarketDayLow': 21.6,
 'regularMarketOpen': 22.66,
 'regularMarketPreviousClose': 22.29,
 'regularMarketPrice': 22.66,
 'regularMarketVolume': 505421,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 79033200,
 'sharesPercentSharesOut': 0.0864,
 'sharesShort': 6832012,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 5164348,
 'shortName': 'Alector, Inc.',
 'shortPercentOfFloat': 0.1507,
 'shortRatio': 9.24,
 'startDate': None,
 'state': 'CA',
 'strikePrice': None,
 'symbol': 'ALEC',
 'threeYearAverageReturn': None,
 'toCurrency': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': -1.826,
 'twoHundredDayAverage': 26.352266,
 'volume': 505421,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.alector.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '94080'}